Funded By FDA, C-Path And NORD To Launch Rare Disease Data Analytics Platform

The Critical Path Institute (C-Path) and the National Organization for Rare Disorders® (NORD) will host a meeting on Tuesday, September 17 in Bethesda, MD to formally launch development of a new rare disease data and analytics platform.

Please to read the entire article.

You must be logged in to post a comment Login